Chair: Alice Cheng (CAN)
| 18:45 – 18:48 | Welcome and introduction | Alice Cheng (CAN) |
| 18:48 – 19:01 | Early control matters | Kamlesh Khunti (UK) |
| 19:01 – 19:14 | A patient centered approach with semaglutide | John Wilding (UK) |
| 19:14 – 19:27 | Treatment of ASCVD in T2D | Kim Conelly (CAN) |
| 19:27 – 19:40 | Managing T2D later in the disease journey | Filip Knop (DNK) |
| 19:40 – 19:53 | Time to focus on optimal utilization of GLP-1 RAs in clinical practice | Tina Vilsbøll (DNK) |
| 19:53 – 20:13 | Panel Discussion and Q&A | All speakers |
| 20:13 – 20:15 | Closing remarks | Alice Cheng (CAN) |
- 21.09.2022
- 18:45 - 20:15
- Hirsch Hall
